Currently holds positions in PTC Therapeutics Inc, Xenon Pharmaceuticals Inc and Global Blood Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | PTC Therapeutics Inc | June 13, 2016 - |
Independent Director | Xenon Pharmaceuticals Inc | Sept. 27, 2016 - |
Independent Director | Global Blood Therapeutics Inc | Dec. 19, 2018 - |
Director | Endocyte Inc | None - |
Independent Director | Medivation Inc | Dec. 1, 2014 - Sept. 28, 2016 |
Interim Chief Commercial Officer, Director | Medivation Inc | July 10, 2014 - Dec. 1, 2014 |
Independent Director | Medivation Inc | April 1, 2013 - July 10, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-24 | 2023-08-24 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
25,000
-50.0%
38.70967,500 USD |
25,000 -50.0% | 38.70 | 967,500 USD | |
2023-05-11 | 2023-05-09 |
ACELYRIN Inc
(SLRN)
|
B Purchase |
15,000
+inf%
18.00270,000 USD |
15,000 +inf% | 18.00 | 270,000 USD | |
2022-06-22 | 2022-06-21 | PS Planned sale |
1,908
-26.2%
27.2451,983 USD |
1,908 -26.2% | 27.24 | 51,983 USD | ||
2022-06-10 | 2022-06-09 |
PTC Therapeutics Inc
(PTCT)
|
S Sale |
738
-2.5%
27.2020,074 USD |
738 -2.5% | 27.20 | 20,074 USD | |
2022-05-18 | 2022-05-16 |
Adverum Biotechnologies Inc
(ADVM)
|
B Purchase |
30,000
+150.0%
0.8525,578 USD |
30,000 +150.0% | 0.85 | 25,578 USD | |
2022-01-11 | 2022-01-07 |
PTC Therapeutics Inc
(PTCT)
|
S Sale |
510
-1.9%
38.5319,648 USD |
510 -1.9% | 38.53 | 19,648 USD | |
2021-06-21 | 2021-06-18 | PS Planned sale |
1,609
-30.4%
36.5458,793 USD |
1,609 -30.4% | 36.54 | 58,793 USD | ||
2021-06-11 | 2021-06-09 |
PTC Therapeutics Inc
(PTCT)
|
S Sale |
365
-1.3%
41.8915,288 USD |
365 -1.3% | 41.89 | 15,288 USD | |
2021-04-01 | 2021-03-31 |
Adverum Biotechnologies Inc
(ADVM)
|
B Purchase |
20,000
+inf%
10.02200,338 USD |
20,000 +inf% | 10.02 | 200,338 USD | |
2021-02-02 | 2021-02-01 |
PTC Therapeutics Inc
(PTCT)
|
S Sale |
506
-1.8%
56.9628,820 USD |
506 -1.8% | 56.96 | 28,820 USD | |
2020-06-19 | 2020-06-19 | PS Planned sale |
881
-28.1%
64.4256,750 USD |
881 -28.1% | 64.42 | 56,750 USD | ||
2020-06-19 | 2020-06-19 | PS Planned sale |
1,663
-34.6%
63.69105,913 USD |
1,663 -34.6% | 63.69 | 105,913 USD | ||
2020-06-12 | 2020-06-11 |
PTC Therapeutics Inc
(PTCT)
|
S Sale |
364
-1.4%
48.3617,603 USD |
364 -1.4% | 48.36 | 17,603 USD |